ABBV-323

ABBV-323 is an antagonist to CD40 being investigated to treat Crohn’s Disease.

Type of Molecule

Biologic

Target

CD40

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Crohn's Disease (CD) n/a
Phase 1